Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023)

Universe Pharmaceuticals (UPC) has 4 years of Long-Term Deferred Tax data on file, last reported at $599078.0 in Q3 2023.

• For the quarter ending Q3 2023, Long-Term Deferred Tax fell 55.55% year-over-year to $599078.0; the trailing twelve-month figure through Sep 2023 stood at $599078.0 (down 55.55% YoY), and the FY2023 full-year result was $599078.0, down 55.55% from the prior year.
• Long-Term Deferred Tax fell to $599078.0 in Q3 2023, from $830259.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $186.5 billion in Q3 2020 to a low of $599078.0 in Q3 2023.
• A 4-year average of $31.1 billion and a median of $927979.0 in 2021 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax sank 100.0% in 2021 and soared 54.91% in 2022, its largest moves.
• Tracing UPC's Long-Term Deferred Tax over 4 years: stood at $186.5 billion in 2020, then slumped by 100.0% to $869997.0 in 2021, then soared by 54.91% to $1.3 million in 2022, then sank by 55.55% to $599078.0 in 2023.
• Business Quant data shows UPC's Long-Term Deferred Tax at $599078.0 in Q3 2023, $830259.0 in Q1 2023, and $1.3 million in Q3 2022.